Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

1959 • 14,850 citations

Interpretation of Changes in Health-related Quality of Life

2003 • 4,060 citations

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

2003 • 2,871 citations

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials

1995 • 2,804 citations

Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

1996 • 2,541 citations

Cancer burden in the year 2000. The global picture

2001 • 2,206 citations

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

2000 • 2,156 citations

Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens

2000 • 1,359 citations

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1992 • 619 citations

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1993 • 394 citations

Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the lung cancer symptom scale

1994 • 236 citations

Design and analysis of non‐inferiority mortality trials in oncology

2002 • 236 citations

Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

1999 • 217 citations

A Comparison of Approximate Interval Estimators for the Bernoulli Parameter

1996 • 197 citations

ALIMTA® (pemetrexed disodium) as second-line treatment ofnon-small-cell lung cancer: a phase II study

2003 • 121 citations

The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting

2002 • 51 citations

34 Phase II study of LY231514 in patients with advanced non-small cell lung cancer (NSCLC)

1997 • 14 citations

Current Data with Pemetrexed in Non–Small-Cell Lung Cancer

2003 • 6 citations

Current data with pemetrexed (Alimta) in non-small-cell lung cancer.

2003 • 4 citations